Urgent need for blood tests as UK cancer diagnoses fall by 50,000

Goodbody Health | Blood Test
[shareaholic app="share_buttons" id_name="post_below_content"]

NHS England chiefs are concerned that the public is being put off seeking help when they have cancer symptoms because they do not want to be a burden to the health service.

The numbers seem to back this up. Macmillan Cancer Support have reported nearly 50,000 fewer cancer diagnoses across the UK since the start of the pandemic. Evidence shows that survival chances reduce the longer the period until diagnoses.

Health Minister Maria Caulfield said the message from the NHS is clear, “The NHS is open.” NHS England cancer director Dame Cally Palmer added, “It was vital people did not delay now even though hospitals were under huge strain.”

Mark Howells, Chief Executive Officer of Goodbody Health, a leading provider of community blood testing and wellness products, said, “We are fully supportive of the NHS in encouraging people to have regular check-ups. We understand the importance of prevention and detection of any illness before symptoms appear. If this gives you the opportunity to change the outcome then we can only see this as a positive action.”  Marc added, “The screening services we offer via our existing network of clinics and partnering with community pharmacies have an important role to play in taking the pressure off GPs and hospitals. Moreover, the in-clinic results give people immediate peace of mind or the knowledge to seek further help.”

Goodbody Health Inc.  (CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF) are a wellness company, focusing on the Health and Wellness of customers through the local community by the introduction and use of cutting edge diagnostic equipment.

Disrupting the ‘old model’ of courier to laboratory style testing.

Goodbody Health has distribution which, when combined with its marketing expertise, digitisation skills and commercialisation with 3rd party science and diagnostic technologies is a powerful combination.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

Search

Search